Details for 2015852227
Up to date per 03.04.2026
Actions
Details for 2015852227
Granted/Registered
European Patent
30.08.2017 A
05.08.2020 B1
21.10.2014
IN
2343MU2014
C12N 1/14 20060101AFI20180129BHEP
Owner
Gennova Biopharmaceuticals Ltd.P-1 IT-BT Park MIDC Phase-2 Hinjwadi, Pune - 411057IN
Representative
Representative
Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT
Inventor
RAGHUWANSHI, ArjunGENNOVA Vaccine Formulation Centre and Research Laboratory BTS-2 Building Chrysalis Enclave Block-2 Plot-2 International Biotech Park Phase II MIDC Hinjwadi Pune Maharashtra 411057IN
SINGH KUMAR, ShrawanGENNOVA Vaccine Formulation Centre and Research Laboratory BTS-2 Building Chrysalis Enclave Block-2 Plot-2 International Biotech Park Phase II MIDC Hinjwadi Pune Maharashtra 411057IN
KUMAR, AnkitGENNOVA Vaccine Formulation Centre and Research Laboratory BTS-2 Building Chrysalis Enclave Block-2 Plot-2 International Biotech Park Phase II MIDC Hinjwadi Pune Maharashtra 411057IN
SAHOO RANJAN, MihirGENNOVA Vaccine Formulation Centre and Research Laboratory BTS-2 Building Chrysalis Enclave Block-2 Plot-2 International Biotech Park Phase II MIDC Hinjwadi Pune Maharashtra 411057IN
SINGH, SanjayGENNOVA Vaccine Formulation Centre and Research Laboratory BTS-2 Building Chrysalis Enclave Block-2 Plot-2 International Biotech Park Phase II MIDC Hinjwadi Pune Maharashtra 411057IN
Information about Fees